{"title":"Palmoplantar Keratoderma: A Mechanism-Based Disease Classification.","authors":"Jia-Wei Liu, Xiaerbati Habulieti, Yue-Tong Qian, Xiao Ma, Yangyang Han, Dong-Lai Ma","doi":"10.2147/CCID.S613425","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Palmoplantar keratoderma (PPK) represents a diagnostically challenging group of genodermatoses due to its extensive genetic heterogeneity. Although multiple causative genes have been identified, the clinical utility of these discoveries remains limited, because few studies directly compare how distinct molecular mechanisms translate into divergent clinical phenotypes.</p><p><strong>Methods: </strong>We describe and analyze three paradigmatic PPK cases with genetically confirmed diagnoses involving <i>SERPINB7</i>-related Nagashima-type PPK, <i>TRPV3</i>-related Olmsted spectrum disorder, and <i>KRT1</i>-associated PPK. Clinical features, disease severity, and genetic mutations were systematically compared. These observations generated a novel classification framework and were then integrated with a comprehensive review of contemporary literature to contextualize and support the comparative findings.</p><p><strong>Results: </strong>Three patients with palmoplantar keratoderma (PPK) harboring distinct pathogenic variants were analyzed and comparatively evaluated. Despite overlapping clinical features, these cases corresponded to three distinct pathogenic mechanisms: defective barrier homeostasis, overactive signaling, and structural collapse. A mechanism-based classification framework was established accordingly. Through comprehensive literature review, 56 PPK-associated genes were identified, the majority of which could be systematically assigned to the three mechanistic categories based on their primary molecular functions.</p><p><strong>Conclusion: </strong>This study highlights that clinically overlapping PPK phenotypes arise from distinct molecular mechanisms. Our mechanism-based classification provides a framework linking genotype to pathogenesis, which may improve diagnostic precision, support the development of mechanism-targeted therapeutic strategies, and thereby advancing personalized management in hereditary PPK.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"19 ","pages":"613425"},"PeriodicalIF":2.5000,"publicationDate":"2026-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13559880/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical, Cosmetic and Investigational Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CCID.S613425","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Palmoplantar keratoderma (PPK) represents a diagnostically challenging group of genodermatoses due to its extensive genetic heterogeneity. Although multiple causative genes have been identified, the clinical utility of these discoveries remains limited, because few studies directly compare how distinct molecular mechanisms translate into divergent clinical phenotypes.
Methods: We describe and analyze three paradigmatic PPK cases with genetically confirmed diagnoses involving SERPINB7-related Nagashima-type PPK, TRPV3-related Olmsted spectrum disorder, and KRT1-associated PPK. Clinical features, disease severity, and genetic mutations were systematically compared. These observations generated a novel classification framework and were then integrated with a comprehensive review of contemporary literature to contextualize and support the comparative findings.
Results: Three patients with palmoplantar keratoderma (PPK) harboring distinct pathogenic variants were analyzed and comparatively evaluated. Despite overlapping clinical features, these cases corresponded to three distinct pathogenic mechanisms: defective barrier homeostasis, overactive signaling, and structural collapse. A mechanism-based classification framework was established accordingly. Through comprehensive literature review, 56 PPK-associated genes were identified, the majority of which could be systematically assigned to the three mechanistic categories based on their primary molecular functions.
Conclusion: This study highlights that clinically overlapping PPK phenotypes arise from distinct molecular mechanisms. Our mechanism-based classification provides a framework linking genotype to pathogenesis, which may improve diagnostic precision, support the development of mechanism-targeted therapeutic strategies, and thereby advancing personalized management in hereditary PPK.
期刊介绍:
Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. Normal and pathological processes in skin development and aging, their modification and treatment, as well as basic research into histology of dermal and dermal structures that provide clinical insights and potential treatment options are key topics for the journal.
Patient satisfaction, preference, quality of life, compliance, persistence and their role in developing new management options to optimize outcomes for target conditions constitute major areas of interest.
The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care.
All areas of dermatology will be covered; contributions will be welcomed from all clinicians and basic science researchers globally.